NCT01387074

Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity

A Prospective, Non-interventional, Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 108 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, non-interventional, observational study to collect data on the use of botulinum toxin Type A in a routine setting in patients with upper limb adult spasticity.

Conditions

• Muscle Spasticity

Interventions

Type	Name	Description
BIOLOGICAL	botulinum toxin Type A	Botulinum toxin Type A treatment at a dose determined by the physician at Baseline followed by a second botulinum toxin Type A treatment approximately 12 weeks later if applicable.

Timeline

• Start date: 2011-06-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2011-07-04
• Last updated: 2014-02-03
• Results posted: 2014-02-03

Locations

1 site across 1 country: Germany